RAP 0.00% 20.5¢ raptor resources limited

Ann: Continued Use of ResAppDx at COVID-19 Respiratory Clinic, page-138

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. 724 Posts.
    lightbulb Created with Sketch. 356
    @Royboy1955

    They never said they were not worried about being a diagnostic tool (which SleepCheck has the successful clinical studies to be) this could be something they pursue in the next few years. This has been discussed so many times and it makes perfect sense for them to enter the space as a screening tool. We already have it over any other product in the space on tech alone. We will be partners as well as the go to reccomended app for the condition by certified boards and organisations globally just as we already are with the Australian Sleep Health Foundation. To say we will never surpass Snorelab based of 5 weeks of public availability is a bit of a joke is it not?
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.